Verition Fund Management LLC Immunity Bio, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 40,663 shares of IBRX stock, worth $141,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,663
Previous 20,200
101.3%
Holding current value
$141,913
Previous $108,000
137.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
218Shares Held
63.4MCall Options Held
1.44MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$48.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.9 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$27.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$13.7 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$5.99 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.4B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...